PM360

OCTOBER 22, 2024

Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs). Even straightforward interactions like the initial prescription can be cluttered with unnecessary overlap and misalignment. It can have a real impact on the external perception of the brand.

Patients 59

Patients Healthcare Provider Pharma Prescription 59

PM360

SEPTEMBER 30, 2024

This integration allows patients to book appointments, access their medication history, and manage prescriptions all in one place, simplifying their experience. Start by creating an integrated digital platform that combines appointment scheduling with pharmaceutical services.

Patients 59

Patients Education Doctors Pharmaceutical 59

Clarivate

SEPTEMBER 5, 2024

This blog summarizes a portion of the data collected, which was previously shared in a poster presented at the May 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference (Read the poster ). Nearly early 1 in 5 expect to withdraw some Medicare Advantage plans from the market due to the law (see figure 4).

Insurance 52

Insurance Marketing Manufacturing Prescription 52

PM360

SEPTEMBER 30, 2024

But commercializing an oncology product in 2024 means identifying and linking to an authentic shortfall in the lived experience of a patient with cancer, not just a perceived gap in the market. Until recently, commercialization of an oncology product was similar to any other pharmaceutical launch.

Side effects 52

Side effects Marketing Patients Specialization 52

pharmaphorum

JANUARY 24, 2023

Healthcare has a substantial carbon footprint, approximately 4% of global emissions and, of that, medicines generate up to one third. So far, only eight of the top 100 pharmaceutical companies by global prescription medicines sales have made a net zero commitment in the same date range.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

Pharmaceutical Representative Training

JUNE 22, 2024

In an effort to reduce the hazards connected with their use, regulations seek to regulate the prescription and distribution of these drugs. The Department of Justice (DOJ) accused this company of providing lavish meals, entertainment, and speaker fees to healthcare providers (HCPs) to induce them to prescribe their drugs.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

PM360

NOVEMBER 12, 2023

We can expect individual states to continue advancing their own privacy legislation, and cookies are officially disappearing after June 30, 2024, to boot. And what are the best tools and techniques to optically target patients and healthcare providers without running afoul of new regulations?

Patients 52

Patients Marketing Medical Pharmaceutical 52

Pharmaceutical Technology

JANUARY 6, 2023

Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya. However, Novartis did not get the same reception while facing similar allegations in Greece.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97